EXLS · Investment summary · as of 4 August 2026
Priced close to what the business has demonstrated
Business type: Compounder · mature and structurally stable
Size is the strategy's, set against its own position and exposure limits.
At $34.24, EXLS requires a 3% five-year revenue growth rate to justify its enterprise value — less than the business already delivers, at 14%.
The market is paying 14.05x NTM EBIT - the 9th percentile of the name own five-year range - for a business the filed record says is compounding revenue at 13.6% at a stable 14.9% margin.
The conditions that would settle the disagreement are dated 3y.
The value rests on an exit multiple of 16.1x, a terminal operating margin of 15% and a 8.1% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: CLIENT-CONCENTRATION IMPAIRMENT IN THE AI-SUBSTITUTABLE DIGITAL OPERATIONS BASE.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The market is paying 14.05x NTM EBIT - the 9th percentile of the name own five-year range - for a business the filed record says is compounding revenue at 13.6% at a stable 14.9% margin. |
| What do we forecast? | Revenue growth of 14% demonstrated; a terminal operating margin of 15%; an exit multiple of 16.1x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is +11.0 percentage points. |
| What is it worth? | Twelve-month target $39.33, +15% from the struck price. Scenario-weighted expected return net of costs +14.9%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 27 October 2026 | Next results (date estimated, not issuer-confirmed) | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
| any two consecutive quarterly reporting periods, tested each 10-Q | Digital operations revenue, service-type disaggregation, Note 3… | Digital operations revenue declines no more than 5.0% year-over-year in two consecutive quarters | Digital operations revenue declines more than 5.0% year-over-year in two consecutive quarters |
| any two consecutive quarterly reporting periods, tested each 10-Q | Trailing-twelve-month operating income divided by… | Consolidated GAAP operating margin at or above 13.5% on a trailing-twelve-month basis for two consecutive quarters | Consolidated GAAP operating margin below 13.5% on a trailing-twelve-month basis for two consecutive quarters |
| FY2026 10-K (expected February 2027) or FY2027 10-K (expected February 2028) | Top-ten client concentration as disclosed in Item 1 (Clients) and… | Revenue from the top ten clients falls at or above 30.0% of total revenue in an annual 10-K | Revenue from the top ten clients falls below 30.0% of total revenue in an annual 10-K |
Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.
CLIENT-CONCENTRATION IMPAIRMENT IN THE AI-SUBSTITUTABLE DIGITAL OPERATIONS BASE. Named cause: EXL top ten client relationships are 34.0% of revenue and its top five are 23.9% (FY2025 10-K); its Digital operations service line - the human-delivered BPO base, 39.0% of revenue - is ALREADY contracting, -1.5% year-over-year in Q2 2026 and -1.7% in H1 2026, while Data-and-AI-led grew 30.1%. The permanent-loss scenario is that this is substitution rather than mix shift: that two or three top-ten clients, having bought EXL help building the AI capability, insource or re-price the operations work at renewal instead of migrating it into EXL higher-value line.
Estimated probability 12%, against the 20% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
Trim when EV/NTM EBIT reaches 21.33x - the 5-year median of the name own daily NTM EV/EBIT, i.e. the 50th percentile of its own range. Exit fully above 23.80x, the 5-year p75. On approach to the $39.33 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Is the business worth owning under its declared economic type? |
| Valuation | Met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | CLIENT-CONCENTRATION IMPAIRMENT IN THE AI-SUBSTITUTABLE DIGITAL OPERATIONS BASE. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The strongest case for mispricing is that the business already delivers +11.0 percentage points more growth than the price requires. The most important unresolved uncertainty is the permanent-loss mechanism: CLIENT-CONCENTRATION IMPAIRMENT IN THE AI-SUBSTITUTABLE DIGITAL OPERATIONS BASE. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $30.08, which forces an immediate review.